These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
205 related articles for article (PubMed ID: 28196904)
1. Extracellular Matrix Receptor Expression in Subtypes of Lung Adenocarcinoma Potentiates Outgrowth of Micrometastases. Stevens LE; Cheung WKC; Adua SJ; Arnal-Estapé A; Zhao M; Liu Z; Brewer K; Herbst RS; Nguyen DX Cancer Res; 2017 Apr; 77(8):1905-1917. PubMed ID: 28196904 [TBL] [Abstract][Full Text] [Related]
2. HCG18/miR-34a-5p/HMMR axis accelerates the progression of lung adenocarcinoma. Li W; Pan T; Jiang W; Zhao H Biomed Pharmacother; 2020 Sep; 129():110217. PubMed ID: 32559619 [TBL] [Abstract][Full Text] [Related]
3. LncRNA HMMR-AS1 promotes proliferation and metastasis of lung adenocarcinoma by regulating MiR-138/sirt6 axis. Cai Y; Sheng Z; Chen Y; Wang J Aging (Albany NY); 2019 May; 11(10):3041-3054. PubMed ID: 31128573 [TBL] [Abstract][Full Text] [Related]
4. Identification of a novel glycolysis-related gene signature that can predict the survival of patients with lung adenocarcinoma. Liu C; Li Y; Wei M; Zhao L; Yu Y; Li G Cell Cycle; 2019 Mar; 18(5):568-579. PubMed ID: 30727821 [TBL] [Abstract][Full Text] [Related]
5. Expression of invasion-related extracellular matrix molecules in human glioblastoma versus intracerebral lung adenocarcinoma metastasis. Varga I; Hutóczki G; Petrás M; Scholtz B; Mikó E; Kenyeres A; Tóth J; Zahuczky G; Bognár L; Hanzély Z; Klekner A Cent Eur Neurosurg; 2010 Nov; 71(4):173-80. PubMed ID: 20397122 [TBL] [Abstract][Full Text] [Related]
6. HMMR associates with immune infiltrates and acts as a prognostic biomaker in lung adenocarcinoma. Ma X; Xie M; Xue Z; Yao J; Wang Y; Xue X; Wang J Comput Biol Med; 2022 Dec; 151(Pt A):106213. PubMed ID: 36306573 [TBL] [Abstract][Full Text] [Related]
7. Extracellular matrix alterations in low-grade lung adenocarcinoma compared with normal lung tissue by imaging mass spectrometry. Angel PM; Bruner E; Bethard J; Clift CL; Ball L; Drake RR; Feghali-Bostwick C J Mass Spectrom; 2020 Apr; 55(4):e4450. PubMed ID: 31654589 [TBL] [Abstract][Full Text] [Related]
8. Overexpression of RCC2 Enhances Cell Motility and Promotes Tumor Metastasis in Lung Adenocarcinoma by Inducing Epithelial-Mesenchymal Transition. Pang B; Wu N; Guan R; Pang L; Li X; Li S; Tang L; Guo Y; Chen J; Sun D; Sun H; Dai J; Bai J; Ji G; Liu P; Liu A; Wang Q; Xiao S; Fu S; Jin Y Clin Cancer Res; 2017 Sep; 23(18):5598-5610. PubMed ID: 28606921 [No Abstract] [Full Text] [Related]
9. Mex3a interacts with LAMA2 to promote lung adenocarcinoma metastasis via PI3K/AKT pathway. Liang J; Li H; Han J; Jiang J; Wang J; Li Y; Feng Z; Zhao R; Sun Z; Lv B; Tian H Cell Death Dis; 2020 Aug; 11(8):614. PubMed ID: 32792503 [TBL] [Abstract][Full Text] [Related]
10. Transcription Factors Leading to High Expression of Neuropeptide L1CAM in Brain Metastases from Lung Adenocarcinoma and Clinical Prognostic Analysis. Feng X; Guan N; Xu E; Miao Y; Li C Dis Markers; 2021; 2021():8585633. PubMed ID: 35003395 [TBL] [Abstract][Full Text] [Related]
11. Quantitative proteomics identify Tenascin-C as a promoter of lung cancer progression and contributor to a signature prognostic of patient survival. Gocheva V; Naba A; Bhutkar A; Guardia T; Miller KM; Li CM; Dayton TL; Sanchez-Rivera FJ; Kim-Kiselak C; Jailkhani N; Winslow MM; Del Rosario A; Hynes RO; Jacks T Proc Natl Acad Sci U S A; 2017 Jul; 114(28):E5625-E5634. PubMed ID: 28652369 [TBL] [Abstract][Full Text] [Related]
12. Flotilin-1 promotes the tumorigenicity and progression of malignant phenotype in human lung adenocarcinoma. Guo AY; Liang XJ; Liu RJ; Li XX; Bi W; Zhou LY; Tang CE; Yan A; Chen ZC; Zhang PF Cancer Biol Ther; 2017 Sep; 18(9):715-722. PubMed ID: 28825855 [TBL] [Abstract][Full Text] [Related]
13. Identification of a novel therapeutic candidate, NRK, in primary cancer-associated fibroblasts of lung adenocarcinoma microenvironment. Wei T; Song J; Liang K; Li L; Mo X; Huang Z; Chen G; Mao N; Yang J J Cancer Res Clin Oncol; 2021 Apr; 147(4):1049-1064. PubMed ID: 33387038 [TBL] [Abstract][Full Text] [Related]
14. Overexpression of microRNA-95-3p suppresses brain metastasis of lung adenocarcinoma through downregulation of cyclin D1. Hwang SJ; Lee HW; Kim HR; Song HJ; Lee DH; Lee H; Shin CH; Joung JG; Kim DH; Joo KM; Kim HH Oncotarget; 2015 Aug; 6(24):20434-48. PubMed ID: 25971210 [TBL] [Abstract][Full Text] [Related]
15. LPCAT1 promotes brain metastasis of lung adenocarcinoma by up-regulating PI3K/AKT/MYC pathway. Wei C; Dong X; Lu H; Tong F; Chen L; Zhang R; Dong J; Hu Y; Wu G; Dong X J Exp Clin Cancer Res; 2019 Feb; 38(1):95. PubMed ID: 30791942 [TBL] [Abstract][Full Text] [Related]
16. MicroRNA-147b promotes lung adenocarcinoma cell aggressiveness through negatively regulating microfibril-associated glycoprotein 4 (MFAP4) and affects prognosis of lung adenocarcinoma patients. Feng YY; Liu CH; Xue Y; Chen YY; Wang YL; Wu XZ Gene; 2020 Mar; 730():144316. PubMed ID: 31884109 [TBL] [Abstract][Full Text] [Related]
17. Single-cell transcriptome analysis demonstrates inter-patient and intra-tumor heterogeneity in primary and metastatic lung adenocarcinoma. Liu Y; Ye G; Huang L; Zhang C; Sheng Y; Wu B; Han L; Wu C; Dong B; Qi Y Aging (Albany NY); 2020 Nov; 12(21):21559-21581. PubMed ID: 33170151 [TBL] [Abstract][Full Text] [Related]
18. Tumor-promoting roles of HMMR in lung adenocarcinoma. Wang Q; Wu G; Fu L; Li Z; Wu Y; Zhu T; Yu G Mutat Res; 2023; 826():111811. PubMed ID: 36603370 [TBL] [Abstract][Full Text] [Related]
19. [Establishment of Dual Fluorescent Labeled Human High Bone Metastasis Lung Adenocarcinoma Cell Line and Transcriptomic Characterization Analysis]. Lu Y; Qiu R; Deng Y; Liu X; Du Y Zhongguo Fei Ai Za Zhi; 2024 Apr; 27(4):257-265. PubMed ID: 38769828 [TBL] [Abstract][Full Text] [Related]
20. Synaptotagmin 12 (SYT12) Gene Expression Promotes Cell Proliferation and Progression of Lung Adenocarcinoma and Involves the Phosphoinositide 3-Kinase (PI3K)/AKT/Mammalian Target of Rapamycin (mTOR) Pathway. Liu K; Luo J; Shao C; Ren Z; Sun S; Zhu Y; Zhou H; Jiang Z; Li X; Gu W; Xu Y; Qiang Y; Ren B; Xu L; Wu H; Shen Y Med Sci Monit; 2020 Feb; 26():e920351. PubMed ID: 32108133 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]